Fate Therapeutics Inc
(31189P102)
Funds Reporting Holdings of Fate Therapeutics Inc according to 13F filings
| Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
|---|---|---|---|---|---|
| Casdin Capital LLC | 2,550,000 | $51,765,000k | Jun 30, 2019 | Aug 13, 2019 | |
| Redmile Group LLC | 10,359,666 | $210,301k | Jun 30, 2019 | Aug 14, 2019 | |
| Farallon Capital Management LLC | 2,500,000 | $50,750k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 1,702,897 | $34,569k | Jun 30, 2019 | Aug 14, 2019 | |
| Partner Fund Management LP | 1,547,730 | $31,419k | Jun 30, 2019 | Aug 14, 2019 | |
| Westfield Capital Management Company LP | 858,749 | $17,433k | Jun 30, 2019 | Aug 13, 2019 | |
| Point72 Asset Management LP | 593,500 | $12,048k | Jun 30, 2019 | Aug 14, 2019 | |
| Nikko Asset Management Americas Inc | 508,841 | $10,329k | Jun 30, 2019 | Jul 29, 2019 | |
| 683 Capital Management LLC | 300,000 | $6,090k | Jun 30, 2019 | Aug 14, 2019 | |
| Columbus Circle Investors | 115,532 | $2,345k | Jun 30, 2019 | Aug 2, 2019 | |
| Wexford Capital LP | 110,882 | $2,251k | Jun 30, 2019 | Aug 14, 2019 | |
| EAM Global Investors LLC | 91,332 | $1,854k | Jun 30, 2019 | Aug 14, 2019 | |
| EAM Investors LLC | 70,799 | $1,437k | Jun 30, 2019 | Aug 14, 2019 | |
| Altrinsic Global Advisors LLC | 70,000 | $1,421k | Jun 30, 2019 | Aug 14, 2019 | |
| Lisanti Capital Growth LLC | 61,615 | $1,251k | Jun 30, 2019 | Aug 5, 2019 | |
| Dafna Capital Management LLC | 60,031 | $1,219k | Jun 30, 2019 | Aug 14, 2019 | |
| Tekla Capital Management LLC | 24,379 | $495k | Jun 30, 2019 | Aug 14, 2019 | |
| Baker Avenue Asset Management LP | 20,000 | $406k | Jun 30, 2019 | Aug 14, 2019 | |
| Renaissance Technologies LLC | 11,819 | $240k | Jun 30, 2019 | Aug 12, 2019 |